Major classes of drugs currently in clinical trials include neuroprotectants, stem cell therapies, tau vaccines, humanized antibodies, metabolic modulators, neurotransmitter modulators, DNA modifications, anti-hypertensives, NSAIDs, and a host of various remedy and vitamin treatments [29]
Oral semaglutide (Rybelsus) proves that oral GLP-1 delivery is possible with the right formulation
Effects last several hours
This blend combines two well-documented synthetic peptides commonly referenced in preclinical and laboratory research exploring cellular signalling, tissue-related pathways, and peptide stability within controlled research systems
What time courses appear in the published research
Phase 3 trials have shown a side-effect profile in line with other GLP-1 drugs